Optical Genome Mapping in Hematological Malignancies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Brest
About this trial
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
Eligibility criteria
Qualifiers
Minor/Major Patients
Patients with suspected hemopathies for whom we receive a sample for diagnosis in the chromosomal genetics laboratory or for whom a diagnosis of hemopathy has already been made.
No objection made or consent given
Disqualifiers
Patients under judicial protection (guardianship, curatorship, ...),
Refusal to participate
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov